Noramco™
Bill Grubb has a strong background in pharmaceuticals, with experience in various roles at Noramco™ and Johnson & Johnson. Bill has worked in positions ranging from Sr. Product Director to Vice President Global Sales and Business Development, demonstrating their expertise in commercial functions, strategic planning, and regulatory affairs. Bill has also held roles in operations and chemical development, showcasing their diverse skill set in the pharmaceutical industry. With a background in Chemistry & Physics, Bill has a solid educational foundation to support their professional experience.
Noramco™
Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule III